You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Neurogenic Voiding Dysfunction1 Apr 20111507 THE PREVELANCE OF URINARY CATHTERIZATION IN WOMEN AND MEN WITH MULTIPLE SCLEROSIS Sangeeta Mahajan and Ruth Ann Marrie Sangeeta MahajanSangeeta Mahajan Cleveland, OH More articles by this author and Ruth Ann MarrieRuth Ann Marrie Winnipeg, Canada More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.1486AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To identify the prevalence of urethral catheterization for voiding dysfunction in women and men with Multiple Sclerosis (MS) and patient traits associated with catheter use. METHODS After obtaining IRB exemption, results from the Fall 2005 North American Research Committee On Multiple Sclerosis survey were reviewed, including the Urogenital Distress Inventory (UDI-6), the Short Form-12 (SF-12) inventory, the Patient Determined Disease Steps (PDDS) disability measure, and history of urologic evaluation and treatment. Data were analyzed using descriptive statistics, the chi-square, Student's t-tests, and analysis of variance. RESULTS Of 16,858 surveys mailed, 9702 (25% male and 75% female) were returned. Respondents with major bladder surgery (conduit, diversion or augmentation) were excluded, leaving 9676 respondents. Of these, 2514 (26%) reported utilizing urinary catheterization currently or in the past, including 751 males (32%) and 1763 females (25%). When separated by incidence, 1091 (11%) of patients reported current and 2222 (23%) reported past catheter use. Among catheterizing patients, intermittent self-catheterization was most common (ISC, 81%), followed by transurethral foley catheterization (TFC, 43%) and suprapubic catheterization (SPC, 8%). When separated by gender, males were significantly more likely to catheterize than females (32% versus 24%, p<0.001) and prefer indwelling catheterization methods, with TFC used by 47% of males and 41% of females (p=0.003) and SPC used by 12% of males and 6% of females (p<0.001). Catheter use in any form was significantly associated with longer disease duration (p<0.001), greater physical disability based on a higher mean PDDS score (4.9 versus 3.1, p<0.001), and reduced quality of life (QoL) in all physical and mental components of the SF-12 (p<0.001). Patients who reported catheter use were more likely to report a history of urine leakage and difficult bladder emptying, anticholinergic use, and prior urologic evaluation with urodynamic testing and/or post-void residual measurement (all p<0.001). CONCLUSIONS Although the use of urinary catheterization for voiding dysfunction is common among patients with MS, rates of use among MS patients was previously unknown. This is the first large scale study to demonstrate the significant rates of urinary catheterization in patients with MS and important gender preferences. Despite its necessity, urinary catheterization is associated with reduced QoL, increased physical disability and longer disease duration among patients with MS. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e604 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sangeeta Mahajan Cleveland, OH More articles by this author Ruth Ann Marrie Winnipeg, Canada More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...